Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.20%9.68B | -23.92%9.8B | -10.10%2.52B | -28.59%2.24B | -34.63%2.59B | -17.78%2.45B | -17.90%12.88B | -38.74%2.81B | -16.17%3.13B | -1.26%3.97B |
| Cost of revenue | 0.39%6.85B | -28.42%6.82B | -20.34%1.59B | -28.19%1.69B | -39.53%1.73B | -21.85%1.81B | -8.47%9.53B | -33.57%1.99B | -8.35%2.36B | 13.47%2.87B |
| Gross profit | -4.82%2.83B | -11.13%2.98B | 14.85%938.66M | -29.81%543.83M | -21.85%858.4M | -3.53%637.38M | -36.49%3.35B | -48.49%817.27M | -33.45%774.82M | -26.25%1.1B |
| Operating expense | -1.06%3.17B | -4.07%3.2B | -7.47%750.54M | -1.82%808.4M | -5.19%809.02M | -1.87%832.9M | -33.90%3.34B | -37.26%811.17M | -37.34%823.37M | -30.41%853.28M |
| Operating profit | -49.27%-332.26M | -1,620.80%-222.59M | 2,985.52%188.12M | -444.90%-264.58M | -79.85%49.39M | -3.98%-195.52M | -93.62%14.64M | -97.93%6.1M | 67.59%-48.56M | -6.86%245.13M |
| Net non-operating interest income (expenses) | -23.41%-111.71M | 1.78%-90.51M | -5.37%-24.14M | -19.04%-24.5M | 18.18%-20.32M | 9.54%-21.55M | 9.58%-92.15M | 9.30%-22.91M | 20.03%-20.59M | -3.14%-24.84M |
| Non-operating interest income | 10.69%3.21M | -16.58%2.9M | -18.88%756K | -19.44%638K | -32.29%585K | 3.72%920K | 20.66%3.48M | 61.25%932K | 19.28%792K | 5.11%864K |
| Non-operating interest expense | 23.02%114.91M | -2.32%93.41M | 4.42%24.89M | 17.61%25.14M | -18.66%20.91M | -9.07%22.47M | -8.75%95.63M | -7.72%23.84M | -19.04%21.38M | 3.21%25.7M |
| Net investment income | 13.61%236.4M | 22.22%208.07M | 28.14%88.89M | 161.08%7.43M | -3.72%100.02M | 299.83%11.73M | 3.84%170.23M | 24.32%69.37M | 509.64%2.85M | 7.88%103.89M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 8,467.91%364.14M | 355.06M | 0 | 9.07M | 0 | 4.25M | 0 | 0 | 0 | |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -46.91%-51.94M | 30.74%-35.35M | 91.30%-51.04M | |||||||
| Less:Other special charges | -48.98%7.39M | -71.63%14.48M | ---- | ---- | ---- | ---- | -88.53%51.04M | ---- | ---- | ---- |
| Less:Write off | 113.42%44.55M | --20.87M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | -155.63%-2.59M | -88.28%4.65M | -93.74%892K | 26.24%1.42M | 181.34%715K | -93.56%1.62M | 324.53%39.71M | 402.11%14.25M | -75.01%1.13M | -146.05%-879K |
| Income before tax | -214.75%-262.09M | 166.72%228.41M | 3,537.42%573.48M | -330.02%-280.22M | -57.04%138.87M | -8.21%-203.72M | 129.93%85.63M | 105.98%15.77M | 61.99%-65.17M | -5.18%323.29M |
| Income tax | 120.48%117.98M | 159.79%53.51M | 423.04%166.07M | -404.38%-87.68M | -22.75%42.32M | -38.42%-67.2M | -53.01%20.6M | -49.82%31.75M | 73.03%-17.38M | -49.69%54.78M |
| Net income | -317.31%-380.07M | 168.92%174.9M | 2,648.35%407.41M | -302.99%-192.55M | -64.04%96.56M | 2.29%-136.52M | 119.71%65.04M | 95.11%-15.99M | 55.35%-47.78M | 15.70%268.51M |
| Net income continuous operations | -317.31%-380.07M | 168.92%174.9M | 2,648.67%407.41M | -302.97%-192.55M | -64.04%96.56M | 2.29%-136.52M | 119.71%65.04M | 95.11%-15.99M | 55.34%-47.78M | 15.70%268.52M |
| Noncontrolling interests | 0 | 0 | ||||||||
| Net income attributable to the company | -317.31%-380.07M | 168.92%174.9M | 2,648.35%407.41M | -302.99%-192.55M | -64.04%96.56M | 2.29%-136.52M | 119.71%65.04M | 95.11%-15.99M | 55.35%-47.78M | 15.70%268.51M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -317.31%-380.07M | 168.92%174.9M | 2,648.35%407.41M | -302.99%-192.55M | -64.04%96.56M | 2.29%-136.52M | 119.71%65.04M | 95.11%-15.99M | 55.35%-47.78M | 15.70%268.51M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -317.05%-94.18 | 167.84%43.39 | 2,627.25%101.09 | -300.50%-47.78 | -64.13%24.05 | 2.72%-33.97 | 119.62%16.2 | 95.11%-4 | 55.52%-11.93 | 15.15%67.05 |
| Diluted earnings per share | -317.05%-94.18 | 167.84%43.39 | 2,623.67%100.9468 | -300.06%-47.78 | -64.17%24.0239 | 2.72%-33.97 | 119.62%16.2 | 95.11%-4 | 55.55%-11.9433 | 15.15%67.05 |
| Dividend per share | 0.00%30 | 0.00%30 | 0.00%30 | 0 | 0 | 0 | 0.00%30 | 0.00%30 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |